Compare FBIO & LNZA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FBIO | LNZA |
|---|---|---|
| Founded | 2006 | 2005 |
| Country | United States | United States |
| Employees | 101 | 384 |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 104.6M | 92.3M |
| IPO Year | N/A | N/A |
| Metric | FBIO | LNZA |
|---|---|---|
| Price | $3.28 | $9.01 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 2 |
| Target Price | ★ $16.50 | $14.00 |
| AVG Volume (30 Days) | ★ 809.2K | 3.8K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $29.71 | N/A |
| Revenue Next Year | $49.34 | $113.27 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.33 | $0.14 |
| 52 Week High | $4.53 | $31.50 |
| Indicator | FBIO | LNZA |
|---|---|---|
| Relative Strength Index (RSI) | 46.73 | 43.01 |
| Support Level | $2.47 | $8.15 |
| Resistance Level | $3.96 | $10.06 |
| Average True Range (ATR) | 0.23 | 0.76 |
| MACD | -0.01 | 0.16 |
| Stochastic Oscillator | 21.12 | 59.14 |
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.
LanzaTech Global Inc is a carbon management company transforming waste carbon into sustainable fuels, fabrics, packaging, and nutrition. Its goal is to advance a circular economy where carbon is reused rather than wasted, reducing reliance on virgin fossil resources and supporting supply chain resilience. The company operates in North America, Europe, Middle East, Africa (EMEA), Asia, and Australia.